Year archive

4SC AG — 2015 filings

All 59 regulatory filings released by 4SC AG (VSC) in 2015, sourced directly from the official regulator.

59 Filings

2015 Period

2015 filings (59)

Filing	Released	Lang
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-12-29	German
Release of the Home Member State according to Article 2c of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Regulatory Filings	2015-11-26	English
Announcement: 4SC AG to present at two upcoming investor conferences Report Publication Announcement	2015-11-17	English
Report Publication Announcement 2015 Report Publication Announcement	2015-11-16	English
Hinweis auf Quartalsfinanzbericht vom 01.01.2016 bis zum 31.03.2016 Report Publication Announcement	2015-11-16	German
Datum:16.11.2015 Report Publication Announcement	2015-11-16	German
Q3 Report 2015 Interim / Quarterly Report 9M 2015	2015-11-12	English
Press Release: 4SC announces financial results for the first nine months and the third quarter of 2015 Earnings Release 9M 2015	2015-11-11	English
Announcement: 4SC AG to host conference call on 11 November 2015 to present third quarter results of 2015 Report Publication Announcement	2015-11-04	English
Press Release 4SC AG: World-renowned experts in the field of cancer therapy development discuss 'Epigenetic Regulation of Immunogenicity' at 10th 4SC Scientific Symposium Regulatory Filings	2015-10-08	English
4SC receives funding from the Eurostars programme for further research of its anti-cancer agents with an epigenetic mode of action Regulatory Filings	2015-09-30	English
Announcement: 4SC to present at the upcoming Baader Investment Conference Regulatory Filings	2015-09-09	English
Press Release: 4SC strengthens patent protection for its epigenetic cancer drug candidate 4SC-202 in growth market China Regulatory Filings	2015-08-13	English
Q2 Report 2015 Interim / Quarterly Report H1 2015	2015-08-07	English
Press Release: 4SC announces financial results for the first half of 2015 Earnings Release H1 2015	2015-08-06	English
Announcement: 4SC AG to host conference call on 6 August 2015 to present second quarter results of 2015 Report Publication Announcement	2015-07-31	English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2015-07-31	English
Press Release: 4SC AG announces formal closing of capital increase Capital/Financing Update	2015-07-29	English
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-07-17	German
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-07-17	German
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-07-17	German
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-07-16	German
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-07-10	German
4SC AG secures EUR 29 million from capital increase to finance planned clinical development programme of its cancer compound resminostat Share Issue/Capital Change	2015-07-07	English
4SC AG announces subscription price for new shares from current capital increase Share Issue/Capital Change	2015-07-02	English
Jahresabschluss zum Geschäftsjahr vom 01.01.2014 bis zum 31.12.2014 Audit Report / Information FY 2014	2015-07-02	German
Press Release: 4SC strengthens patent protection for lead cancer compound resminostat Regulatory Filings	2015-07-01	English
Press Release: 4SC's partner Yakult Honsha enters with cancer compound resminostat further indications and starts clinical Phase I study in patients with pancreatic or biliary tract cancer in Japan Regulatory Filings	2015-06-26	English
4SC AG plans to issue new shares to finance the further development of its epigenetic lead anti-cancer compound resminostat Capital/Financing Update	2015-06-22	English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 27.07.2015 in Planegg-Martinsried mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2015-06-17	German
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-06-03	German
Press Release: 4SC presents final results from Phase I AEGIS trial as well as rationale for daily dosing scheme of 4SC-205 cancer compound at ASCO Regulatory Filings	2015-06-03	English
Jahresabschluss zum Geschäftsjahr vom 01.01.2014 bis zum 31.12.2014 Annual Report FY 2014	2015-06-01	German
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2015-05-29	English
Konzernabschluss zum Geschäftsjahr vom 01.01.2014 bis zum 31.12.2014 Annual Report FY 2014	2015-05-26	German
Press Release: 4SC Announces Financial Results for the First Quarter of 2015 Earnings Release Q1 2015	2015-05-07	English
Q1 Report 2015 Interim / Quarterly Report Q1 2015	2015-05-07	English
4SC to present at three upcoming investor conferences Regulatory Filings	2015-05-04	English
Announcement: 4SC AG to host conference call on 7 May 2015 to present first quarter results of 2015 Report Publication Announcement	2015-04-30	English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2015-04-30	English
4SC announces implementation of 5:1 reverse share split in line with planning Share Issue/Capital Change	2015-04-27	English
Press Release: 4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan M&A Activity	2015-04-14	English
4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan M&A Activity	2015-04-14	English
Announcement: 4SC to present at the upcoming Kempen & Co Life Sciences Conference Regulatory Filings	2015-04-10	English
Annual Financial Statements 2014 Annual Report FY 2014	2015-04-08	English
Annual Financial Statements 2014 Annual Report FY 2014	2015-04-08	German
Press Release 4SC AG: Dr Susanne Danhauser-Riedl joins 4SC as Chief Medical Officer to strengthen management and clinical development team Board/Management Information	2015-04-01	English
Press Release: 4SC presents new immunotherapeutic activity data of its epigenetic cancer drug resminostat at the ECCO ITOC conference 2015 Regulatory Filings	2015-03-26	English
Press Release: 4SC publishes results for financial year 2014 Earnings Release FY 2014	2015-03-25	English
Announcement: 4SC to host conference call on 25 March 2015 to present annual results 2014 Report Publication Announcement	2015-03-19	English
Press Release: 4SC's associated company Panoptes Pharma concludes license agreement with Mediolanum for compound PP-001 for inflammatory eye diseases Regulatory Filings	2015-02-10	English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 11.03.2015 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2015-01-29	German
4SC AG plans Extraordinary General Meeting and reduction of share capital Share Issue/Capital Change	2015-01-23	English
Report Publication Announcement 2015 Report Publication Announcement	2015-01-14	English
Report Publication Announcement 2015 Report Publication Announcement	2015-01-14	English
Hinweis auf Quartalsfinanzbericht vom 01.01.2014 bis zum 31.03.2014 Report Publication Announcement	2015-01-14	German
Datum:14.01.2015 Report Publication Announcement	2015-01-14	German
Press Release 4SC AG: BEYOND RESEARCH initiative of 4SC Discovery and CRELUX reaches first milestone in drug discovery project for Helmholtz Zentrum Munchen Regulatory Filings	2015-01-13	English
Press Release 4SC AG: Prof. Dr. Helga Rubsamen-Schaeff and Joerg von Petrikowsky join the Supervisory Board of 4SC AG Board/Management Information	2015-01-12	English

Filings by year

2025 3 filings
2024 1 filing
2023 4 filings
2022 4 filings
2021 6 filings
2020 14 filings
2019 45 filings
2018 39 filings
2017 55 filings
2016 34 filings
2015 59 filings
2014 43 filings
2013 39 filings
2012 67 filings
2011 60 filings
2010 42 filings
2009 47 filings
2008 38 filings
2007 78 filings
2006 38 filings
2005 3 filings